Fresenius Medical Care AG (NYSE:FMS) Shares Sold by Pzena Investment Management LLC

Pzena Investment Management LLC cut its stake in shares of Fresenius Medical Care AG (NYSE:FMS - Free Report) by 5.8% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 15,283,025 shares of the company's stock after selling 932,644 shares during the period. Pzena Investment Management LLC owned about 2.60% of Fresenius Medical Care worth $346,008,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the stock. Smartleaf Asset Management LLC raised its position in shares of Fresenius Medical Care by 192.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company's stock valued at $28,000 after buying an additional 806 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of Fresenius Medical Care in the third quarter valued at about $38,000. Jones Financial Companies Lllp raised its position in shares of Fresenius Medical Care by 80.5% in the fourth quarter. Jones Financial Companies Lllp now owns 4,510 shares of the company's stock valued at $102,000 after buying an additional 2,012 shares during the last quarter. Venturi Wealth Management LLC raised its position in shares of Fresenius Medical Care by 1,045.8% in the third quarter. Venturi Wealth Management LLC now owns 5,259 shares of the company's stock valued at $112,000 after buying an additional 4,800 shares during the last quarter. Finally, GAMMA Investing LLC raised its position in shares of Fresenius Medical Care by 43.3% in the fourth quarter. GAMMA Investing LLC now owns 7,164 shares of the company's stock valued at $162,000 after buying an additional 2,166 shares during the last quarter. 8.37% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Fresenius Medical Care Stock Up 3.7 %

FMS stock traded up $0.87 during midday trading on Friday, reaching $24.04. 303,252 shares of the company were exchanged, compared to its average volume of 315,456. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.02 and a current ratio of 1.37. Fresenius Medical Care AG has a 1-year low of $17.93 and a 1-year high of $25.25. The stock's 50-day simple moving average is $23.63 and its 200 day simple moving average is $22.14. The company has a market cap of $14.10 billion, a price-to-earnings ratio of 19.86, a price-to-earnings-growth ratio of 0.76 and a beta of 0.99.

Analyst Ratings Changes

FMS has been the subject of several recent analyst reports. Bank of America upgraded shares of Fresenius Medical Care from an "underperform" rating to a "neutral" rating in a research report on Monday, December 2nd. StockNews.com raised shares of Fresenius Medical Care from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, February 5th. Finally, Truist Financial raised their price objective on shares of Fresenius Medical Care from $23.00 to $25.00 and gave the company a "hold" rating in a research note on Monday, January 6th.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.